Pulmonx
LUNG
120 hedge funds and large institutions have $1.14B invested in Pulmonx in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 10 closing their positions.
553% more call options, than puts
Call options by funds: $3.36M | Put options by funds: $515K
131% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 26
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
14.77% more ownership
Funds ownership: 71.35% → 86.13% (+15%)
6% more funds holding
Funds holding: 113 → 120 (+7)
0% less capital invested
Capital invested by funds: $1.14B → $1.14B (-$3.79M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$39.9M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$29M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$24.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.2M |
| 5 |
MGM
Miura Global Management
New York
|
+$19.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$24.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$6.32M |
| 4 |
Blackstone Inc
New York
|
-$1.98M |
| 5 |
Morgan Stanley
New York
|
-$1.82M |
LUNG Hedge Fund Activity: Q3 2021 in Review
120 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q3 2021, worth a combined $1.14B — down 0.33% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new LUNG positions and 10 closed out — a net gain of 9 holders — while 60 added to existing stakes and 26 trimmed.
The largest buyer was Primecap Management, adding an estimated $39.9M. The largest seller was Iron Triangle Partners, exiting entirely with an estimated $24.3M sold.
- 120 institutional investors held Pulmonx (LUNG) as of Q3 2021, up from 113 in Q2 2021.
- Funds reported $1.14B of Pulmonx stock for Q3 2021, down 0.33% quarter-over-quarter.
- 19 funds opened new Pulmonx positions in Q3 2021 and 10 closed out, a net change of +9 holders.
- The largest Pulmonx buyer in Q3 2021 was Primecap Management, an estimated $39.9M added.
- The largest Pulmonx seller in Q3 2021 was Iron Triangle Partners, an estimated $24.3M sold.
Based on aggregated 13F filings for Q3 2021.